NMOSD
Clinical trials for NMOSD explained in plain language.
Never miss a new study
Get alerted when new NMOSD trials appear
Sign up with your email to follow new studies for NMOSD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Promising drug trial for kids with rare nerve disorder
Disease control Recruiting nowThis study tests a drug called satralizumab in children aged 2 to 11 with a rare disease that attacks the nerves in the eyes and spine (NMOSD). The goal is to see how the drug works in the body and if it can prevent relapses. Only 8 children will take part, and they will receive …
Matched conditions: NMOSD
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated May 26, 2026 06:48 UTC
-
Engineered immune cells take aim at lupus and MS
Disease control Recruiting nowThis early-phase study tests a new treatment called RD06-05, which uses a patient's own immune cells modified to target and calm overactive immune responses in autoimmune diseases like lupus, scleroderma, and multiple sclerosis. The main goal is to check safety and how the body h…
Matched conditions: NMOSD
Phase: EARLY_PHASE1 • Sponsor: Nanjing Bioheng Biotech Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 06:43 UTC
-
New registry tracks real-world impact of NMOSD treatments
Knowledge-focused Recruiting nowThis study is a long-term registry that follows about 122 adults with AQP4+ neuromyelitis optica spectrum disorder (NMOSD) who are already prescribed Alexion C5 inhibitor therapies. Researchers will collect data on relapse rates, safety, quality of life, and patient-reported outc…
Matched conditions: NMOSD
Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Knowledge-focused
Last updated May 22, 2026 14:03 UTC